Novel mutations in the inhibitory adaptor protein LNK drive JAK-STAT signaling in patients with myeloproliferative neoplasms
Top Cited Papers
Open Access
- 12 August 2010
- journal article
- Published by American Society of Hematology in Blood
- Vol. 116 (6), 988-992
- https://doi.org/10.1182/blood-2010-02-270108
Abstract
Dysregulated Janus kinase–signal transducer and activator of transcription (JAK-STAT) signaling due to activation of tyrosine kinases is a common feaKeywords
This publication has 21 references indexed in Scilit:
- Lnk inhibits erythropoiesis and Epo-dependent JAK2 activation and downstream signaling pathwaysBlood, 2005
- A Gain-of-Function Mutation ofJAK2in Myeloproliferative DisordersNew England Journal of Medicine, 2005
- Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosisCancer Cell, 2005
- A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia veraNature, 2005
- Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disordersThe Lancet, 2005
- Lnk Inhibits Tpo–mpl Signaling and Tpo-mediated MegakaryocytopoiesisThe Journal of Experimental Medicine, 2004
- Single Cell Profiling of Potentiated Phospho-Protein Networks in Cancer CellsCell, 2004
- Cytokine Signaling and Hematopoietic Homeostasis Are Disrupted in Lnk-deficient MiceThe Journal of Experimental Medicine, 2002
- Enhanced Hematopoiesis by Hematopoietic Progenitor Cells Lacking Intracellular Adaptor Protein, LnkThe Journal of Experimental Medicine, 2002
- Lnk Adaptor: Novel Negative Regulator of B Cell LymphopoiesisScience's STKE, 2001